A magnetic resonance nanoprobe with STING activation character collaborates with platinum-based drug for enhanced tumor immunochemotherapy
Open Access
- 11 December 2021
- journal article
- research article
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 19 (1) , 1-14
Abstract
Background: Immunochemotherapy is a potent anti-tumor strategy, however, how to select therapeutic drugs to enhance the combined therapeutic effect still needs to be explored. Methods and results: Herein, a magnetic resonance nanoprobe (MnP@Lip) with STING (Stimulator of INterferon Genes) activation character was synthesized and co-administered with platinum-based chemotherapeutics for enhanced immunochemotherapy. MnP@Lip nanoparticles was prepared by simple fabrication process with good reproducibility, pH-sensitive drug release behavior and biocompatibility. In vitro experiments elucidated that Mn2+ can promote the polarization of M0 and/or M2 macrophages to M1 phenotype, and promote the maturation of BMDC cells. Upon Mn2+ treatment, the STING pathway was activated in tumor cells, mouse lung epithelial cells, and immune cells. More importantly, anti-tumor experiments in vivo proved that MnP@Lip combined with platinum-based chemotherapeutics increased T cells infiltration in the tumor microenvironment, and inhibited tumor growth in the orthotopic therapeutic and postoperative tumor models. Conclusions: This kind of therapeutic strategy that combined MnP@Lip nanoparticles with platinum-based chemotherapeutics may provide a novel insight for immunochemotherapy. GraphicalKeywords
Funding Information
- National Natural Science Foundation of China (82071889, 81771801)
This publication has 36 references indexed in Scilit:
- Manganese Increases the Sensitivity of the cGAS-STING Pathway for Double-Stranded DNA and Is Required for the Host Defense against DNA VirusesImmunity, 2018
- Implications of macrophage polarization in autoimmunityImmunology, 2018
- Primary, Adaptive, and Acquired Resistance to Cancer ImmunotherapyCell, 2017
- A pH-activatable nanoparticle with signal-amplification capabilities for non-invasive imaging of tumour malignancyNature Nanotechnology, 2016
- Lipid-enveloped zinc phosphate hybrid nanoparticles for codelivery of H-2Kb and H-2Db-restricted antigenic peptides and monophosphoryl lipid A to induce antitumor immunity against melanomaJournal of Controlled Release, 2016
- Manganese Is Essential for Neuronal HealthAnnual Review of Nutrition, 2015
- Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITKProceedings of the National Academy of Sciences, 2015
- STING Contributes to Antiglioma Immunity via Triggering Type I IFN Signals in the Tumor MicroenvironmentCancer Immunology Research, 2014
- Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trialThe Lancet Oncology, 2014
- Induction of anti-tumor cytotoxic T cell responses through PLGA-nanoparticle mediated antigen deliveryBiomaterials, 2011